Takeda Pharmaceutical Company

October 2, 2017October 2, 2017

New Takeda, Karolinska Collaboration to Identify Clinical Targets in IBD

News

A new collaboration to identify and validate clinical targets in inflammatory bowel disease (IBD) was recently announced by Japan’s Takeda Pharmaceutical Company, Sweden’s Karolinska Institutet, and the Structural Genomics Consortium, a ... Read more

May 9, 2017May 9, 2017

Entyvio Safe, Effective for Ulcerative Colitis and Crohn’s, Studies Show

News

Entyvio (vedolizumab) is safe and effective to treat adults with moderate-to-severe active ulcerative colitis (UC) and Crohn’s disease (CD). These results come from eight real-world analyses presented by Takeda Pharmaceutical ... Read more